Results for tag: Jonathan Rosenberg Total Items Found: 4

Sacituzumab Govitecan-hziy: Welcome Addition to Advanced Urothelial Cancer Treatments, but Time to Figure Out Sequencing and Combinations

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 7/12/2021 2:17:23 PM

Pembrolizumab in Second-Line Therapy for Advanced Urothelial Carcinoma

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 7/20/2017 11:22:49 AM

Jonathan E. Rosenberg, MD, and Toni K. Choueiri, MD, on Bladder Cancer: Mutation Burden and Atezolizumab

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2016
Toni Choueiri
Dana-Farber
Jonathan Rosenberg
Memorial Sloan Kettering
bladder cancer
mutation burden
atezolizumab
PD-L1 immunotherapy
progression-free survival
overall survival
intrinsic expression subtype

Created: 6/8/2016 9:55:45 AM

Jonathan E. Rosenberg, MD, on Results of the IMvigor 210 Study on Atezolizumab in Locally Advanced or Metastatic Urothelial Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
ECC 2015
Jonathan Rosenberg
Memorial Sloan Kettering
MSKCC
IMvigor
PDL1
bladder cancer
urothelial
atezolizumab
platinum chemotherapy

Created: 1/31/2016 12:41:22 AM
Order By Item Count
Order Alphabetically